CRICO CRICO home

Recent Coverage

March 1, 2022 Frequency and Nature of Communication and Handoff Failures in Medical Malpractice Claims

Using Candello data, this study examines the characteristics of malpractice claims which miscommunications.

READ MORE >

March 1, 2022 Improving Patient Handoffs Helps Reduce Malpractice Claims

Healthcare Risk Management reports on a large study conducted by Boston Children’s Hospital in which researchers reviewed 498 medical malpractice claims provided by Candello, CRICO’s national medical malpractice collaborative. The work revealed a direct relationship between the quality of patient handoffs and claims.

READ MORE >

January 5, 2022 To Measure and Reduce Diagnostic Error, Start With the Data You Have

This article, published by the Michigan State Medical Society, provides insight into how CRICO's diagnostic process of care framework, using medical malpractice claims data, can be used to reduce diagnostic errors.

READ MORE >
View All News & Research

The Impact of Automated Notification on Follow-up of Actionable Tests Pending at Discharge: A Cluster-Randomized Controlled Trial

  • July 1, 2018

A physician’s failure to follow-up on test results that are still pending at a patient’s discharge (TPADs) could lead to a missed diagnosis or preventable adverse event. This CRICO-funded study researched whether automated notifications improved documented follow-up for tests that were actionable. 


The research concluded that automated notification of actionable TPADs did shorten the follow-up time by physicians for patients within their healthcare network.  However, the researchers noted that future research is needed to evaluate such safety concerns as “The high proportion of actionable TPADs without any documented follow-up (~ 40%).”

 

Citation for the Full-text Article

Dalal AK, Schaffer A, Gershanik EF,Papanna R, Eibensteiner K, Nolido NV, Yoon CS, Williams D, Lipsitz SR, Roy CL, Schnipper JL. The impact of automated notification on follow-up of actionable tests pending at discharge: a cluster-randomized controlled trial. July 2018, 33(7):1043–1051. DOI: 10.1007/s11606-018-4393-y